Signature Wealth Management Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,626
Closed -$212K 104
2022
Q3
$212K Buy
2,626
+47
+2% +$4.22K 0.23% 86
2022
Q2
$231K Hold
2,579
0.24% 88
2022
Q1
$286K Buy
2,579
+619
+32% +$65.4K 0.24% 86
2021
Q4
$203K Hold
1,960
0.17% 101
2021
Q3
$246K Hold
1,960
0.22% 93
2021
Q2
$243K Sell
1,960
-101
-5% -$12.7K 0.22% 91
2021
Q1
$243K Hold
2,061
0.23% 87
2020
Q4
$241K Buy
+2,061
New +$227K 0.24% 81

Other funds holding MDT

Signature Wealth Management Partners's MDT Position: Q4 2022 in Review

Signature Wealth Management Partners sold out of Medtronic (MDT) in Q4 2022, closing a stake of 2,626 shares — an estimated $212K sold.

Signature Wealth Management Partners first reported a position in MDT in Q4 2020 and held it in 8 quarters. The position peaked at $286K in Q1 2022. 1,962 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

  • Signature Wealth Management Partners reported no remaining Medtronic position as of Q4 2022 after selling out during the quarter.
  • Signature Wealth Management Partners sold 2,626 Medtronic shares in Q4 2022, an estimated $212K.
  • Signature Wealth Management Partners first reported a position in Medtronic in Q4 2020 and held it in 8 quarters.
  • Signature Wealth Management Partners's Medtronic position peaked at $286K in Q1 2022.
  • 1,962 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on Signature Wealth Management Partners's 13F filing for Q4 2022, filed 6 Feb 2023.